Spreadsheet: 53504b71-448d-4b41-b8d0-88836cf7bb6e
Sheet: Sheet1

Test Referenced | Entry Type | Mayo ID | Description | Reporting Description | Method | Collection Container | Temperature | Stability | [NAME] | Unit of Measure | [NAME] | Minimum Volume | Reject Due To | Reference Values | Days/Times Performed | Analytic Time | Maximum Lab Time | CPT Units | CPT Code | LOINC® Code | LOINC® Attributes | Always Performed | Orderable Separately | Performing Location
DUP15 | Test | DUP15 | 15q11.2 Duplication, FISH | 15q11.2 Duplication, FISH | Fluorescence In Situ Hybridization (FISH) |  |  |  |  |  | Provide a reason for referral with each specimen. The laboratory will not reject testing if this information is not provided, but appropriate testing and interpretation may be compromised or delayed.   Forms: 1. New York Clients-Informed consent is required. Please document on the request form or electronic order that a copy is on file. An Informed Consent for Genetic Testing (Supply T576) is available in Special Instructions. 2. If not ordering electronically, submit a Cytogenetics/AFP Congenital Disorders Request Form (Supply T238) with the specimen.   Advise Express Mail or equivalent if not on courier service.   Submit only 1 of the following specimens:   Preferred: [NAME]: Green top (sodium heparin) [NAME]: 5 mL Collection Instructions: 1. Invert several times to mix blood. 2. Other anticoagulants are not recommended and are harmful to the viability of the cells. 	 Acceptable: [NAME] fluid Container/Tube: Amniotic fluid container [NAME]: 20-25 mL  Collection Instructions:  1. Optimal timing for specimen collection is during 14 to 18 weeks of gestation, but specimens collected at other weeks of gestation are also accepted. Provide gestational age at the time of amniocentesis. 2. Discard the first 2 mL of amniotic fluid. Additional Information: 1. Place the tubes in a [NAME] container (Supply T329). 2. Fill remaining space with packing material. 3. Unavoidably, about 1% to 2% of mailed-in specimens are not viable. 4. Bloody specimens are undesirable. 5. If the specimen does not grow in culture, you will be notified within 7 days of receipt. 6. Results will be reported and also telephoned or faxed, if requested.   Specimen Type: Chorionic villi Container/Tube: 15-mL tube containing 15 mL of transport media [NAME]: 20-25 mg Collection Instructions: 1. Collect specimen by the transabdominal or transcervical method. 2. Transfer chorionic villi to a Petri dish containing transport medium (Supply T095). 3. Using a stereomicroscope and sterile forceps, assess the quality and quantity of the villi and remove any blood clots and maternal decidua.   [NAME]: Skin biopsy Container/Tube: Sterile container with sterile Hank's balanced salt solution (Supply T132), [NAME]'s solution, or normal saline [NAME]: 4 mm diameter  Collection Instructions: 1. Wash biopsy site with an antiseptic soap. 2. Thoroughly rinse area with sterile water. 3. Do not use alcohol or iodine preparations. 4. A local anesthetic may be used. 5. Biopsy specimens are best taken by [NAME] to include full thickness of dermis. | Amniotic Fluid: 5 mL/Blood: 2 mL | Hemolysis	NA Thawing	NA Lipemia	NA Icterus	NA Other	Clotted blood | An interpretative report will be provided. | Samples processed Monday through Sunday. Results reported Monday through Friday, 8 a.m.-5 p.m. CST. | 12 days | 13 days |  | Profile |  |  |  |  | Rochester
DUP15 | [NAME] | VARIES | Varies |  |  |  | Ambient
DUP15 | Order Question | G_478 | Source |  | Answer List
DUP15 | Option | G_478-1 | Whole blood Na Hep
DUP15 | Option | [NAME] | Amniotic Fluid
DUP15 | Option | [NAME] | [NAME]
DUP15 | Option | G_478-4 | [NAME]
DUP15 | Order Question | [NAME] | Reason For Referral |  | Plain Text
DUP15 | Result | 30106 | [NAME] | [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 31208-2
DUP15 | Result | 30130 | [NAME] | [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
DUP15 | Result | G_478 | Source | Source | Alphanumeric
DUP15 | Result | 30134 | Order Date | Order Date | Alphanumeric
DUP15 | Result | [NAME] | Reason For Referral | Reason For Referral | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 42349-1
DUP15 | Result | 30136 | Method | Method | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 49549-9
DUP15 | Result | 30137 | Result | Result | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
DUP15 | Result | 30138 | Interpretation | Interpretation | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 69965-2
DUP15 | Result | 30139 | Amendment | Amendment | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
DUP15 | Result | 30147 | Reveiwed By | Reveiwed By | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
DUP15 | Result | 30148 | Release Date | Release Date | Alphanumeric
DUP15 | Billing Component | DUP15 |  | Interp and report |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 88291
DUP15 | Billing Component | DUP15 |  | Chromosomal in situ hybridization |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 88273
DUP15 | Billing Component | DUP15 |  | DNA Probe, each |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 | 88271